Every round on record, with the sources behind each and the investors on them.
An Indian formulations company
linuxlaboratories.inLinkedInChennaiHealthtechFounded 2007Over 1800 professionals people
2 sources · checked 4 times, last 17h ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
Neither source states a round stage, lead investor, or valuation. Tata Capital Healthcare Fund II is described as exiting, not investing in this round.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round | $70M incl. secondary | 2026-09-30 | not stated | No recent discussion |
2 sources · checked 4 times, last 17h ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 2 sources
Neither source states a round stage, lead investor, or valuation. Tata Capital Healthcare Fund II is described as exiting, not investing in this round. | ||||
1 person on 2 outlets
Found on X with Firecrawl search
Linux Laboratories develops and markets affordable specialty medicines for healthcare professionals and patients, focusing on CNS/neuropsychiatry plus dermatology, nutraceuticals and cardio-diabetic therapies in India and international markets.
Linux addresses unmet CNS and neuropsychiatry needs with affordable specialty formulations and has expanded into dermatology, cardio-diabetics and nutraceuticals, reaching more than 60,000 doctors with over 125 brands spanning about 400 SKUs. Its $70 million equity transaction with ChrysCapital and Tata Capital Healthcare Fund III is intended to fund new therapies, brand acquisitions, manufacturing and R&D as it expands into adjacent therapeutic areas and international markets.
Checked against 8 sources 3d ago